Evidence map›Paper›PMID 40746793›Full record

ArticleCureus2025

Immune Thrombocytopenia Triggered by Sildenafil-Containing Rhino 69 Platinum 1000: A Case Report.

Aishwarya Saripalli, Rupam Sharma, Kevin T Dao, Kasey Fox

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aishwarya SaripalliInternal Medicine, Kern Medical Center, Bakersfield, USA.
Rupam SharmaInternal Medicine, Kern Medical Center, Bakersfield, USA.
Kevin T DaoInternal Medicine, Kern Medical Center, Bakersfield, USA.
Kasey FoxInternal Medicine, Kern Medical Center, Bakersfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-induced immune thrombocytopenia (DITP) is a rare but serious complication resulting from exposure to certain medications, herbal products, and dietary supplements. Although various agents have been implicated, sildenafil-containing over-the-counter supplements have not previously been associated with this phenomenon. Herein, we report a case of a 24-year-old male who presented with diffuse purpuric rash, gum bleeding, and epistaxis over three days. Laboratory testing revealed severe isolated thrombocytopenia (platelet count of 4,000/µL). Extensive workup for infectious, hepatic, autoimmune, and thrombotic etiologies was unremarkable. Upon further history, the patient disclosed use of "Rhino 69 Platinum 1000," an unregulated sexual enhancement supplement containing undeclared sildenafil over the prior two weeks. He received intravenous immunoglobulin (IVIG) and high-dose dexamethasone with a rapid platelet recovery. After discontinuing the supplement, his platelet counts normalized, and he remained symptom-free during one year of follow-up. No other cause of thrombocytopenia was identified. This report highlights a probable case of DITP associated with the use of "Rhino 69 Platinum 1000." To our knowledge, this is a rare reported case implicating this supplement or sildenafil as a potential trigger for DITP.

Indexed as

diagnosisdrug-induced immune thrombocytopeniamechanismrhino 69sildenafiltreatment

Identifiers

PMID40746793
PMCPMC12310413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.